Literature DB >> 25279408

Assessing the harms of polypharmacy requires careful interpretation and consistent definitions.

Lisa Kouladjian, Sarah N Hilmer, Timothy F Chen, David G Le Couteur, Danijela Gnjidic.   

Abstract

Mesh：

Year:  2014        PMID： 25279408      PMCID： PMC4243917          DOI： 10.1111/bcp.12359

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

Review 1.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Susan M Patterson; Carmel Hughes; Ngaire Kerse; Chris R Cardwell; Marie C Bradley
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  The effects of polypharmacy in older adults.

Authors:  S N Hilmer; D Gnjidic
Journal:  Clin Pharmacol Ther       Date:  2008-11-26       Impact factor: 6.875

3.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

4.  The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study.

Authors:  Rupert A Payne; Gary A Abel; Bruce Guthrie; Stewart W Mercer
Journal:  CMAJ       Date:  2013-02-19       Impact factor: 8.262

5.  Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.

Authors:  Rupert A Payne; Gary A Abel; Anthony J Avery; Stewart W Mercer; Martin O Roland
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

6.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

7.  Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients.

Authors:  Christoph Strehblow; Michael Smeikal; Peter Fasching
Journal:  Wien Klin Wochenschr       Date:  2014-01-21       Impact factor: 1.704

8.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

Authors:  Cynthia M Boyd; Jonathan Darer; Chad Boult; Linda P Fried; Lisa Boult; Albert W Wu
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

9.  High-risk prescribing and incidence of frailty among older community-dwelling men.

Authors:  D Gnjidic; S N Hilmer; F M Blyth; V Naganathan; R G Cumming; D J Handelsman; A J McLachlan; D R Abernethy; E Banks; D G Le Couteur
Journal:  Clin Pharmacol Ther       Date:  2012-02-01       Impact factor: 6.875

10.  Polypharmacy patterns: unravelling systematic associations between prescribed medications.

Authors:  Amaia Calderón-Larrañaga; Luis A Gimeno-Feliu; Francisca González-Rubio; Beatriz Poblador-Plou; María Lairla-San José; José M Abad-Díez; Antonio Poncel-Falcó; Alexandra Prados-Torres
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240
  10 in total
  5 in total

Review 1.  Polypharmacy and potentially inappropriate medication use in geriatric oncology.

Authors:  Manvi Sharma; Kah Poh Loh; Ginah Nightingale; Supriya G Mohile; Holly M Holmes
Journal:  J Geriatr Oncol       Date:  2016-08-03       Impact factor: 3.599

2.  Response to: assessing the harms of polypharmacy requires careful interpretation and consistent definitions.

Authors:  Rupert A Payne; Gary A Abel; Anthony J Avery; Stewart W Mercer; Martin O Roland
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

3.  Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.

Authors:  Theresa W Kim; Alexander Y Walley; Timothy C Heeren; Gregory J Patts; Alicia S Ventura; Gabriel B Lerner; Nicholas Mauricio; Richard Saitz
Journal:  J Subst Abuse Treat       Date:  2017-07-14

4.  Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model.

Authors:  Timothy F Chen
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

5.  Exploring polypharmacy with artificial intelligence: data analysis protocol.

Authors:  Caroline Sirois; Richard Khoury; Audrey Durand; Pierre-Luc Deziel; Olga Bukhtiyarova; Yohann Chiu; Denis Talbot; Alexandre Bureau; Philippe Després; Christian Gagné; François Laviolette; Anne-Marie Savard; Jacques Corbeil; Thierry Badard; Sonia Jean; Marc Simard
Journal:  BMC Med Inform Decis Mak       Date:  2021-07-20       Impact factor: 2.796
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.